Immunobiological characterization of cancer stem cells isolated from glioblastoma patients.
about
Methodology for Anti-Gene Anti-IGF-I Therapy of Malignant TumoursA New Biological Feature of Natural Killer Cells: The Recognition of Solid Tumor-Derived Cancer Stem CellsCancer Stem Cell Hierarchy in Glioblastoma MultiformeMelanoma Cancer Stem Cells: Markers and FunctionsCancer stem cells and immunoresistance: clinical implications and solutionsExploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell VaccinesImmune responses to human cancer stem-like cells/cancer-initiating cellsIntegrating Immune Checkpoint Blockade with Anti-Neo/Mutated Antigens Reactivity to Increase the Clinical Outcome of ImmunotherapyImmunotherapy advances for glioblastomaUnderstanding glioma stem cells: rationale, clinical relevance and therapeutic strategiesAn update on vaccine therapy and other immunotherapeutic approaches for glioblastomaAdoptive cell therapies for glioblastomaDendritic Cell-Based Immunotherapy Treatment for Glioblastoma MultiformeImmune-related conditions and subsequent risk of brain cancer in a cohort of 4.5 million male US veterans.Cytokine induction of VCAM-1 but not IL13Rα2 on glioma cells: a tale of two antibodies.Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cellsNOS2 expression in glioma cell lines and glioma primary cell cultures: correlation with neurosphere generation and SOX-2 expression.Hypoxia potentiates glioma-mediated immunosuppressionLPS alters the immuno-phenotype of glioma and glioma stem-like cells and induces in vivo antitumor immunity via TLR4Cancer stem cell plasticity and tumor hierarchy.Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma?Immune therapeutic targeting of glioma cancer stem cells.Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.Cancer stem cells in glioblastomaNatural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain.Immunobiology and signaling pathways of cancer stem cells: implication for cancer therapy.Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cellsHead and Neck Cancer Stem Cells: From Identification to Tumor Immune NetworkThe early antitumor immune response is necessary for tumor growth: Re-visiting Prehn's hypothesis in the human melanoma system.Digital transcriptome profiling of normal and glioblastoma-derived neural stem cells identifies genes associated with patient survivalStem-like tumor-initiating cells isolated from IL13Rα2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T CellsNK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell PhenotypeProstate cancer stem cells are targets of both innate and adaptive immunity and elicit tumor-specific immune responsesGlioma stem cells and immunotherapy for the treatment of malignant gliomas.Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model.Effects of Malignant Melanoma Initiating Cells on T-Cell ActivationBIX01294, an inhibitor of histone methyltransferase, induces autophagy-dependent differentiation of glioma stem-like cells.A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cells.Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand.
P2860
Q21284986-AFFEDCFC-7CF8-4FE1-A97B-B79E44029964Q26744651-8951EC3C-3641-4FDC-B70E-01DA7EB04B83Q26752312-34B59F97-6517-48DC-94ED-29324A11277DQ26765435-310051AB-2C64-4217-B9FE-B877CC3F79B6Q26769757-177B64FD-8CCD-4EA3-9C7D-A4203937BA7AQ26772715-F304C38B-A2B7-4E2D-9E6A-0050DFF82988Q26781794-0BC12648-6BDD-4E8E-B9BC-F14E61B05AB0Q26783783-F2C1A931-7D00-458B-A426-CA58BB80DA2FQ26866513-85847A32-1FE8-4FE6-9654-3BF4D185C995Q26995698-FF11EC08-939B-4523-8EF0-0A3D61D8EA9BQ27024830-C9835B50-EB1C-4BC2-88AA-397A2B453EEDQ27030863-1EE479CF-1C72-48FA-82CD-B3407791B846Q28087485-4882DAC0-2CE6-4109-B229-E9233A01C304Q28383237-AD6F2E1E-3D7D-4BD6-A90B-E859F428721CQ33559926-67B81480-CC79-49E5-92EE-F0EC15E42D53Q33564357-D6A0CFF6-DD5C-4026-9A69-6883CF14DC4CQ33648954-2288BF79-0C69-4AD4-B9A0-C2F15E797C30Q33809268-28B78D91-FCC8-4E7C-B0AD-881E7A436F81Q33824394-F10A4D67-9C48-4FAF-8005-B4AC912EB172Q34459650-64AC4DEB-C8E1-41F1-B258-CBD42EC435B0Q34480557-F876FD71-46F3-47FF-AFF2-CED39D74FC95Q34676437-8DF25423-7437-432B-B435-8368A8CCBBE5Q35269551-0E490552-85F0-415E-9ECA-B9F92CB0E175Q35829972-24007C0B-BAE2-4E92-BCFD-26CA058B6C4EQ35878535-C6A7BCBA-6D48-4F01-A3DD-1E6EDB10B241Q35984406-11836E74-572D-4AC2-AF83-E691F570E711Q36060236-12F6102F-071B-4FF2-A1D4-80A9073CA8B0Q36212296-5424292D-F7E2-4C5F-A763-36E6C0E8BCE9Q36373379-DBA6EAA4-CA4F-42DB-B181-A35034C2B2FBQ36566768-C7F47A95-B1A5-4C1E-BD56-9AF2F616DD6AQ36626774-C4DCDD2D-1566-4DEE-90D0-55C7DAD51B52Q36660550-5DFEA8D4-47AD-48EC-8737-6859E62B426DQ36887869-FD6BFE34-A30C-40BE-A200-14835F3B1447Q36898699-FEC77E91-8B86-4237-8739-BE9089904F5CQ37031739-9891A396-903B-464A-9980-2CFDD865F3B6Q37116163-59FE6D79-4236-4667-B421-F104A7589A37Q37487279-6CC3F26F-68BB-422F-82D1-BECACEEB3007Q37580507-6731DE96-E093-4925-A587-3FBD203BCF9EQ37615286-00A8A806-163D-46A9-BDC0-61E1C6538F5EQ37637062-D4C4B531-A851-40E6-9427-1F99DDAB956B
P2860
Immunobiological characterization of cancer stem cells isolated from glioblastoma patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Immunobiological characterizat ...... ed from glioblastoma patients.
@ast
Immunobiological characterizat ...... ed from glioblastoma patients.
@en
type
label
Immunobiological characterizat ...... ed from glioblastoma patients.
@ast
Immunobiological characterizat ...... ed from glioblastoma patients.
@en
prefLabel
Immunobiological characterizat ...... ed from glioblastoma patients.
@ast
Immunobiological characterizat ...... ed from glioblastoma patients.
@en
P2093
P2860
P1476
Immunobiological characterizat ...... ed from glioblastoma patients.
@en
P2093
Alberto Franzin
Cristina Maccalli
Daniela Clavenna
Francesco M Marincola
Giorgio Parmiani
Gloria Sovena
Pietro Mortini
Rossella Galli
Soldano Ferrone
P2860
P304
P356
10.1158/1078-0432.CCR-09-2730
P407
P577
2010-01-26T00:00:00Z